Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis

NCT05116098 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Tuberculosis

Interventions

COMBINATION_PRODUCT: zinc 50 mg + Epigallocatechin gallate

Sponsor

Ministry of Health, Saudi Arabia